None listed
Conditions
Interventions
None listed
Sponsors
Chung-Ang Univerisity Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age: 19 years and older. 2. Individuals newly diagnosed with advanced or metastatic cancer or those experiencing cancer recurrence. 3. Participants who have voluntarily decided to enroll in this clinical trial.
Exclusion criteria
Exclusion criteria: 1. Patients who have initiated or are undergoing chemotherapy for cancers meeting the inclusion criteria before enrolling in a clinical trial. 2. Pregnant women or those with the potential for pregnancy. 3. Patients currently admitted to the Intensive Care Unit (ICU). 4. Individuals with serious illnesses, including uncontrolled psychiatric conditions, requiring prioritized management over participation in clinical research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence Rates of Cancer Cachexia and Muscle Atrophy: A Comprehensive and Cancer-Specific Analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| Association Between Cancer Cachexia, Sarcopenia, Treatment Response Rates, Treatment Toxicity, Survival Duration, and Quality of Life;Exploration of Surrogate Markers Reflecting Cancer Cachexia and Muscle Atrophy (e.g., NLR, cachexia index, triceps skinfold-albumin index);Progression of Cancer Cachexia and Muscle Atrophy Based on Treatment Stage and Timing;Incidence of Thrombosis | — |
Countries
Korea, Republic of
Contacts
Public ContactSong EE PARK
Chung-Ang Univerisity Hospital
Outcome results
None listed